FindTrial
Sign In

A medical records based study for EBV and CMV infection in patients with rheumatic diseases and their relationship with diseases

EBV and CMV infection in patients with rheumatic diseases and their relationship with diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044001
Enrollment
Unknown
Registered
2021-03-06
Start date
2021-02-21
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatic diseases (mainly systemic lupus erythematosus, rheumatoid arthritis, sjogren's syndrome)

Interventions

Infection group:None
No infection group:None

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 82 Years

Inclusion criteria

Inclusion criteria: 1) Patients with rheumatic diseases that meet the latest international diagnostic classification standards of the corresponding diseases; 2) Nucleic acid test of EBV or CMV was performed.

Exclusion criteria

Exclusion criteria: Patients who met any of the following criteria were not included in the study: 1) Complicated with other blood system diseases, such as lymphoma and leukemia; 2) Patients with other infections.

Design outcomes

Primary

MeasureTime frame
EBV CMV DNA;—

Countries

China

Contacts

Public ContactLingli Dong

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

dongll@tjh.tjmu.edu.cn+86 18672912727

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026